R0041/2026-04-01/Q002/S02¶
WebSearch — FDA AI healthcare clinical decision support sycophancy
Summary¶
| Field | Value |
|---|---|
| Source/Database | WebSearch |
| Query terms | FDA AI healthcare clinical decision support disagreement safety sycophantic |
| Filters | None |
| Results returned | 10 |
| Results selected | 3 |
| Results rejected | 7 |
Selected Results¶
| Result | Title | URL | Rationale |
|---|---|---|---|
| S02-R01 | The illusion of safety: A report to the FDA on AI healthcare | https://pmc.ncbi.nlm.nih.gov/articles/PMC12140231/ | PMC paper on FDA AI oversight gaps including sycophancy |
| S02-R02 | FDA medical device loophole could cause patient harm | https://www.healthcareitnews.com/news/fda-medical-device-loophole-could-cause-patient-harm-study-warns | Reporting on LLM-specific risks in clinical settings |
| S02-R03 | AI in Health Care and the FDA's Blindspot | https://ldi.upenn.edu/our-work/research-updates/ai-in-health-care-and-the-fdas-blind-spot/ | Penn analysis of FDA regulatory gaps |
Rejected Results¶
Notes¶
Healthcare searches found that sycophancy is being discussed as a patient safety risk by researchers, but the FDA has not issued guidance specifically addressing sycophantic LLM behavior.